| (Values in U.S. Thousands) | Mar, 2026 | Mar, 2025 | Mar, 2024 | Mar, 2023 | Mar, 2022 |
| Sales | 13,830 | 14,780 | 2,410 | 13,180 | 6,310 |
| Sales Growth | -6.43% | +513.28% | -81.71% | +108.87% | +260.57% |
| Net Income | -18,670 | -134,980 | -9,460 | -1,360 | -16,850 |
| Net Income Growth | +86.17% | -1,326.85% | -595.59% | +91.93% | +51.62% |
Akso Health Group ADR (AHG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Akso Health Group operates a social e-commerce platform principally in China which collaborates with other domestic e-commerce platforms and offers users a product. In addition, the Company also plans to develop a new business as a cancer therapy and radiotherapy oncology service provider. Akso Health Group, formerly known as Xiaobai Maimai Inc., is based in BEIJING.
Fiscal Year End Date: 03/31